39753-81-6

Basic information

• Product Name: (4-NITRO-PYRAZOL-1-YL)-ACETIC ACID ETHYL ESTER
• Synonyms: AKOS B016147;AKOS PAO-0927;(4-NITRO-PYRAZOL-1-YL)-ACETIC ACID ETHYL ESTER;ETHYL 2-(4-NITRO-1H-PYRAZOL-1-YL)ACETATE;ART-CHEM-BB B016147;ethyl (4-nitro-1H-pyrazol-1-yl)acetate;2-(4-nitro-1-pyrazolyl)acetic acid ethyl ester;2-(4-nitropyrazol-1-yl)acetic acid ethyl ester
• CAS NO: 39753-81-6
• Molecular Formula: C7H9N3O4
• Molecular Weight: 199.16
• Mol File: 39753-81-6.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (4-NITRO-PYRAZOL-1-YL)-ACETIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: (4-NITRO-PYRAZOL-1-YL)-ACETIC ACID ETHYL ESTER(39753-81-6)
• EPA Substance Registry System: (4-NITRO-PYRAZOL-1-YL)-ACETIC ACID ETHYL ESTER(39753-81-6)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 39753-81-6(Hazardous Substances Data)

Usage

General Description

(4-NITRO-PYRAZOL-1-YL)-ACETIC ACID ETHYL ESTER is a chemical compound with the molecular formula C7H7N3O5. It is an ester derivative of (4-nitro-pyrazol-1-yl)-acetic acid, and is often used as a building block in the synthesis of pharmaceuticals and agrochemicals. (4-NITRO-PYRAZOL-1-YL)-ACETIC ACID ETHYL ESTER has potential applications in the field of medicinal chemistry, as it can be used to create new compounds with biological activity. It is important to handle and use this chemical with caution, as it may pose risks to human health and the environment if not properly managed.

Upstream product

• 2075-46-9 4-nitro-1H-pyrazole 
• 105-36-2 ethyl bromoacetate 
• 637-80-9 ethyl 2-hydrazinylacetate 
• 181294-57-5 β-formyl-β-nitroenamine 

Downstream Products

• 6645-69-8 2-(4-nitro-1H-pyrazol-1-yl)acetic acid 
• 1152841-53-6 ethyl 2-(4-amino-1H-pyrazol-1-yl)acetate 
• 1339619-68-9 N-methyl-2-(4-nitro-1H-pyrazol-1-yl)acetamide 
• 1152853-30-9 2-(4-amino-1H-pyrazol-1-yl)-N-methylacetamide 

Relevant articles and documents

A METHOD FOR THE PREPARATION OF N-HETERYLPYRAZOLES FROM 4-NITROPYRAZOLE

-

JAK INHIBITORS

Described herein are Janus kinase (JAK) inhibitors and methods of utilizing JAK inhibitors in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.

Five-And-Six-Membered Heterocyclic Compound, And Preparation Method, Pharmaceutical Composition And Use Thereof

A five-and-six-membered heterocyclic compound as represented by general formula I, pharmaceutically acceptable salt, metabolite, metabolic precursors or drug precursors thereof, preparation method, pharmaceutical composition, and use thereof; the five-and-six-membered heterocyclic compound has activity as a Janus kinase (JAK) inhibitor, and can be used to prepare drugs for treating diseases caused by the abnormal activity of kinase, such as cell proliferation diseases like cancer.